Suppr超能文献

蛋白质制剂开发的科学与艺术。

Science and art of protein formulation development.

机构信息

Biological Development, Bayer USA, LLC, 800 Dwight Way, Berkeley, CA 94710, United States.

Pharmaceutical Research and Development, Pfizer Biotherapeutics Pharmaceutical Sciences, Chesterfield, MO 63017, United States.

出版信息

Int J Pharm. 2019 Sep 10;568:118505. doi: 10.1016/j.ijpharm.2019.118505. Epub 2019 Jul 12.

Abstract

Protein pharmaceuticals have become a significant class of marketed drug products and are expected to grow steadily over the next decade. Development of a commercial protein product is, however, a rather complex process. A critical step in this process is formulation development, enabling the final product configuration. A number of challenges still exist in the formulation development process. This review is intended to discuss these challenges, to illustrate the basic formulation development processes, and to compare the options and strategies in practical formulation development.

摘要

蛋白质类药物已成为上市药品的重要类别,预计在未来十年内将稳步增长。然而,商业蛋白质产品的开发是一个相当复杂的过程。在这个过程中,关键步骤是制剂开发,使最终产品的配置得以实现。在制剂开发过程中仍然存在许多挑战。本文旨在讨论这些挑战,说明基本的制剂开发过程,并比较实际制剂开发中的选择和策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验